5 Stocks To Gain From Medical Device Excise Tax Exemption

The Bottom Line

At the moment, the future of the MedTech industry looks bright, courtesy an expanding global population, rising popularity of digital healthcare services and the rapid development of technological know-how and its incorporation in the healthcare sector.  Amid all these factors, we believe the medical device excise tax suspension makes for a key catalyst in this booming industry.

With global Medtech sales expected to grow at a CAGR of 4.1% to roughly $478 billion by 2020 (as per Evaluate Ltd.), we believe the aforementioned stocks can be promising additions to your healthcare portfolio, backed by positive momentum in share price and solid future earnings growth projections.

1 2 3 4
View single page >> |


How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.


Leave a comment to automatically be entered into our contest to win a free Echo Show.